LUAD tumors; matching adjacent non-cancerous tissues; xenograft tumors
16HBE; A549; H1299; H1975
cell line-derived xenograft
proliferation (promotes); migration (promotes); invasion (promotes); apoptosis (inhibits); immune regulation (promotes); glycolysis (promotes); mRNA stability (promotes); m6A modification (promotes)
RT-qPCR; RNA-seq; Clinical Sample Validation; Bioinformatics Analysis; Transfection; CCK8; Colony Formation Assay; Annexin V/PI Flow Cytometry; Wound Healing Assay; Transwell Assay; Flow Cytometry(Non-apoptosis/cycle); ELISA; RIP (RNA Immunoprecipitation); CLIP; FISH / smFISH; RNA Pull-Down; Actinomycin D / DRB Stability Assay; MeRIP / MeRIP-seq; Western Blot; In Vivo Animal Model; IF (Immunofluorescence); Survival Analysis; ROC Analysis
High hsa_circ_0000376 expression is associated with advanced TNM staging, lymph node metastasis, inferior overall survival, and prognostic utility with AUC 0.7917 for forecasting patient mortality.
hsa_circ_0000376 is upregulated in LUAD tissues and cell lines and high expression is associated with advanced TNM stage, lymph node metastasis, and poor overall survival. Functionally, it promotes LUAD cell proliferation, migration, invasion, tumor growth, glycolytic activity, and neutrophil N2 polarization while suppressing apoptosis. Mechanistically, hsa_circ_0000376 binds IGF2BP3 and stabilizes SLC2A1 mRNA, defining a hsa_circ_0000376/IGF2BP3/SLC2A1 regulatory axis in LUAD.
0.8611
The IGF2BP3/SLC2A1 axis mediates hsa_circ_0000376-Induced malignant progression and neutrophil N2 polarization in the lung adenocarcinoma microenvironment.
combined biological and clinical study